1. Home
  2. GOAI vs LONA Comparison

GOAI vs LONA Comparison

Compare GOAI & LONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eva Live Inc. Common Stock

GOAI

Eva Live Inc. Common Stock

N/A

Current Price

$1.79

Market Cap

83.5M

Sector

Technology

ML Signal

N/A

Logo LeonaBio Inc. Common Stock

LONA

LeonaBio Inc. Common Stock

HOLD

Current Price

$3.44

Market Cap

71.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOAI
LONA
Founded
2015
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.5M
71.2M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
GOAI
LONA
Price
$1.79
$3.44
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
★ $10.00
AVG Volume (30 Days)
★ 181.6K
113.1K
Earning Date
04-10-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 966.67
N/A
EPS
★ N/A
N/A
Revenue
★ $17,037,328.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 82.59
N/A
52 Week Low
$1.42
$2.21
52 Week High
$6.67
$14.21

Technical Indicators

Market Signals
Indicator
GOAI
LONA
Relative Strength Index (RSI) 39.31 25.91
Support Level $1.62 N/A
Resistance Level $2.66 $8.77
Average True Range (ATR) 0.32 0.94
MACD -0.08 -0.40
Stochastic Oscillator 3.77 24.69

Price Performance

Historical Comparison
GOAI
LONA

About GOAI Eva Live Inc. Common Stock

Eva Live Inc is a United States-based technology company that has developed an automated and intelligent advertiser campaign management platform, Eva Platform, which enables advertisers ('customers, clients') to buy advertising space on several digital channels to reach their desired audience. The company also works with Businesses that utilize its in-house digital marketing capabilities, including advice, creative services, account management, production of advertising materials, media planning, and buying.

About LONA LeonaBio Inc. Common Stock

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Share on Social Networks: